Literature DB >> 33792784

Diabetes and glycemic control in necrotizing otitis externa (NOE).

Chilaf Peled1, Re'em Sadeh2, Sabri El-Saied3, Victor Novack2, Daniel M Kaplan3.   

Abstract

PURPOSE: Although the association between necrotizing otitis externa (NOE) and diabetes mellitus (DM) is well known, there is little knowledge in regards to the effects of DM and glycemic control on the outcome of NOE. The aim of the study was to determine the effects of DM duration and glycemic control, and in-hospital glycemic control on NOE severity.
METHODS: A retrospective case series analysis, including all patients hospitalized between 1990 and 2018 due to NOE were included. Data collected included NOE disease characteristics, duration of DM, DM-associated comorbidities, glycated hemoglobin (HbA1c), urine microalbumin and in-hospital blood glucose measurements. Disease severity was defined based on duration of hospitalization (above or below 20 days) and need for surgery.
RESULTS: Eighty-nine patients were included in the study. Eighty-three patients (94.3%) had DM. Preadmission HbA1c was 8.13% (5.8-12.6%). Forty-nine patients (65.5%) had mean blood glucose of ≥ 140 mg/dL and 26 (34.5%) had ≤ 140 mg/dL. DM duration was 157.88 months among NOE patients who required surgery, and 127.6 months among patients who were treated conservatively (p value 0.25). HbA1c in patients hospitalized < 20 days was 7.6%, and 8.7% among NOE hospitalized ≥ 20 days (p value 0.027). Seven patients with mean blood glucose of ≤ 140 mg/dL had Pseudomonas Aeruginosa (PA-NOE) (26.7%), in comparison to 25 (51.0%) with mean blood glucose measurement of ≥ 140 mg/dL (p = 0.045).
CONCLUSIONS: HbA1c at admission is associated with longer hospitalization duration among NOE patients. Mean blood glucose during hospitalization was associated with a higher likelihood of PA infection, however, it had no effect on disease outcome.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Diabetes mellitus; Ear canal; External ear; Malignant; Skull base osteomyelitis

Mesh:

Substances:

Year:  2021        PMID: 33792784     DOI: 10.1007/s00405-021-06772-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  15 in total

Review 1.  Management of malignant (necrotising) otitis externa.

Authors:  S Hollis; K Evans
Journal:  J Laryngol Otol       Date:  2011-10-03       Impact factor: 1.469

Review 2.  The diagnostic criteria of malignant external otitis.

Authors:  D Cohen; P Friedman
Journal:  J Laryngol Otol       Date:  1987-03       Impact factor: 1.469

3.  Necrotizing Otitis Externa-Analysis of 83 Cases: Clinical Findings and Course of Disease.

Authors:  Chilaf Peled; Sabri El-Seid; Anat Bahat-Dinur; Lital Rahmani Tzvi-Ran; Mordechai Kraus; Daniel Kaplan
Journal:  Otol Neurotol       Date:  2019-01       Impact factor: 2.311

4.  Cranial nerve involvement in malignant external otitis: implications for clinical outcome.

Authors:  Navin Mani; Holger Sudhoff; Sandeep Rajagopal; David Moffat; Patrick R Axon
Journal:  Laryngoscope       Date:  2007-05       Impact factor: 3.325

Review 5.  Diagnosis and treatment of necrotising otitis externa and diabetic foot osteomyelitis - similarities and differences.

Authors:  C Peled; M Kraus; D Kaplan
Journal:  J Laryngol Otol       Date:  2018-08-28       Impact factor: 1.469

Review 6.  Necrotizing otitis externa: a systematic review.

Authors:  Pouya Mahdyoun; Céline Pulcini; Ivan Gahide; Charles Raffaelli; Charles Savoldelli; Laurent Castillo; Nicolas Guevara
Journal:  Otol Neurotol       Date:  2013-06       Impact factor: 2.311

7.  Necrotizing external otitis: a report of 46 cases.

Authors:  Valerie Franco-Vidal; Harold Blanchet; Cécile Bebear; Hervé Dutronc; Vincent Darrouzet
Journal:  Otol Neurotol       Date:  2007-09       Impact factor: 2.311

8.  Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa.

Authors:  Leonard Berenholz; Udi Katzenell; Moshe Harell
Journal:  Laryngoscope       Date:  2002-09       Impact factor: 3.325

9.  Malignant otitis externa: an Asian perspective on treatment outcomes and prognostic factors.

Authors:  Shaun Loh; Woei Shyang Loh
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04-04       Impact factor: 3.497

10.  Predicting outcome of malignant external otitis.

Authors:  Ben Zion Joshua; Jaqueline Sulkes; Eyal Raveh; Jihad Bishara; Ben I Nageris
Journal:  Otol Neurotol       Date:  2008-04       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.